183 related articles for article (PubMed ID: 9204204)
1. Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.
Gagel RF
Cancer Treat Res; 1997; 89():421-41. PubMed ID: 9204204
[TBL] [Abstract][Full Text] [Related]
2. [Multiple endocrine neoplasia type 2a and 2b].
Vestergaard P
Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
[TBL] [Abstract][Full Text] [Related]
3. Application of genetic screening information to the management of medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Wohllk N; Cote GJ; Evans DB; Goepfert H; Ordonez NG; Gagel RF
Endocrinol Metab Clin North Am; 1996 Mar; 25(1):1-25. PubMed ID: 8907678
[TBL] [Abstract][Full Text] [Related]
4. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
5. [Multiple endocrine neoplasia syndromes. Type 2].
Juodele L; Juozaityte E; Zindzius A; Pundzius J
Medicina (Kaunas); 2005; 41(4):281-94. PubMed ID: 15864001
[TBL] [Abstract][Full Text] [Related]
6. [Multiple endocrine neoplasia type 2].
Maia AL; Gross JL; Puñales MK
Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):725-34. PubMed ID: 16444355
[TBL] [Abstract][Full Text] [Related]
7. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
[TBL] [Abstract][Full Text] [Related]
8. [From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].
Hofstra RM; van der Luijt RB; Lips CJ
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2217-21. PubMed ID: 11757244
[TBL] [Abstract][Full Text] [Related]
9. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Pfragner R; Behmel A; Lorenzo MJ
Genes Chromosomes Cancer; 1995 Mar; 12(3):209-12. PubMed ID: 7536460
[TBL] [Abstract][Full Text] [Related]
10. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.
Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S
J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine neoplasia type 2.
Lodish M
Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
[TBL] [Abstract][Full Text] [Related]
13. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
14. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
Lodish MB; Stratakis CA
Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
[TBL] [Abstract][Full Text] [Related]
15. [Results of treating medullary thyroid carcinoma: the differences between sporadic and inherited forms].
Wygoda Z; Włoch J; Gubała E; Wiench M; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():422-31. PubMed ID: 12182060
[TBL] [Abstract][Full Text] [Related]
16. Multiple endocrine neoplasia type 2.
Forster-Gibson CJ; Mulligan LM
Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
[No Abstract] [Full Text] [Related]
17. Sporadic and familial medullary thyroid carcinoma: state of the art.
Moo-Young TA; Traugott AL; Moley JF
Surg Clin North Am; 2009 Oct; 89(5):1193-204. PubMed ID: 19836492
[TBL] [Abstract][Full Text] [Related]
18. RET gene and its implications for cancer.
Goodfellow PJ; Wells SA
J Natl Cancer Inst; 1995 Oct; 87(20):1515-23. PubMed ID: 7563185
[TBL] [Abstract][Full Text] [Related]
19. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
20. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).
Jimenez C; Gagel RF
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
